ACT for Hip Osteoarthritis in India: Joint Preservation Before Replacement | ALIV

Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV

Hip osteoarthritis is one of the most debilitating joint conditions in India's middle-aged and older adult population — producing groin pain, restricted hip rotation, limping gait, and progressive loss of independence. While knee OA has attracted the most clinical attention in regenerative medicine, hip OA is equally responsive to ACT's anti-inflammatory and chondroprotective paracrine mechanism — and patients with hip OA have even fewer non-surgical alternatives than knee OA patients, making the ACT deferral strategy particularly clinically relevant.

Hip ACT: The Anatomical Consideration

The hip joint is a deep ball-and-socket joint — significantly deeper and less accessible than the knee for intra-articular injection. This is the primary technical difference between hip and knee ACT at ALIV: hip intra-articular injections are routinely performed under ultrasound or fluoroscopic guidance to ensure accurate placement of the ACT preparation in the joint space. This is a standard requirement for hip injection in clinical practice and does not add significant complexity or risk — but it does require the radiological guidance infrastructure that ALIV's clinical setting provides. The ACT preparation itself, and the growth factor mechanism, are identical between hip and knee applications.

The clinical goals for hip OA ACT mirror those for knee OA: meaningful reduction in groin and hip pain; improved hip range of motion, particularly internal rotation (the movement most restricted by OA-related cartilage loss and capsular fibrosis); reduced analgesic and NSAID requirement; and functional improvement in walking distance and stair-climbing. Response in hip OA is broadly similar to knee OA in ALIV's clinical experience — approximately 70% of appropriately selected patients (Kellgren-Lawrence grade II–III) show meaningful improvement at six months. See: ACT for osteoarthritis.

Who Is an Appropriate Hip OA ACT Candidate

The ideal hip OA ACT patient: moderate disease (KL grade II–III on X-ray, some joint space preserved); age 55–70 where total hip replacement implant longevity is a genuine concern for early surgery; adequate femoral head sphericity (severe femoral head deformity from avascular necrosis or severe OA may not respond as predictably); and ongoing physiotherapy for hip abductor and gluteal strengthening that provides the mechanical context for ACT's biological support. Patients with complete cartilage loss (KL grade IV, protrusion acetabuli) or significant leg length discrepancy from hip deformity are not the primary ACT target — surgical reconstruction is the more appropriate clinical priority for these presentations.

Is hip ACT more technically difficult than knee ACT?

The image-guided hip injection requires a radiologist or musculoskeletal-trained physician comfortable with hip joint access under imaging guidance — a standard clinical skill in ALIV's procedural environment. From the patient's perspective, the procedure is no more uncomfortable than the knee equivalent under adequate local anaesthesia. The guidance equipment means the patient may be positioned on a fluoroscopy table or ultrasound couch — the ALIV team briefs patients on the specific setup for their procedure.

Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.